Better ankle implant aims to last longer and reduce pain

NCT ID NCT06941558

Ongoing Disease control Sponsor: Northumbria Healthcare NHS Foundation Trust Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 200 people who received a new type of ankle replacement designed to attach better to bone and wear out more slowly. Researchers will track pain, function, and how long the implant lasts over time. The goal is to see if this improved device helps people with severe ankle arthritis move better and have less pain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: INFINITY™ with ADAPTIS™ and EVERLAST™ ankle replacement system (a medical device)
What this could lead to: If successful, this could confirm that the new ankle implant lasts longer and works better than older versions, improving mobility and reducing pain for people with severe ankle arthritis.
What could go wrong: This is an observational follow-up study, not a randomized trial, so results may be less definitive. The implant could still wear out or require revision surgery in some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE ANKLE ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TOTAL ANKLE ARTHROPLASTY TOTAL ANKLE REPLACEMENT

Contacts and locations

Locations

Northumbria Healthcare NHS Foundation Trust

Newcastle, NE29 8NH, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.